Skip to content
10-K

Annual Report

WEREWOLF THERAPEUTICS, INC. HOWL

0001785530-25-000008

← back to feed
Filed
Mar 11, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Mar 5, 2025 44.83M sh
Long Term Debt FY 2024 · Dec 31, 2024 $32.09M
Shares Diluted FY 2024 · Dec 31, 2023 35.65M sh
Capex FY 2024 · Dec 31, 2023 $769K
Operating Cash Flow FY 2024 · Dec 31, 2023 −$32.61M
Cash And Equivalents FY 2024 · Dec 31, 2023 $134.34M
Current Liabilities FY 2024 · Dec 31, 2023 $19.38M
Total Liabilities FY 2024 · Dec 31, 2023 $63.46M
Current Assets FY 2024 · Dec 31, 2023 $138.37M
Total Assets FY 2024 · Dec 31, 2023 $174.83M
Eps Diluted FY 2024 · Dec 31, 2023 −$1.05
Eps Basic FY 2024 · Dec 31, 2023 −$1.05
Sga Expense FY 2024 · Dec 31, 2023 $18.67M
Rd Expense FY 2024 · Dec 31, 2023 $41.78M
Net Income FY 2024 · Dec 31, 2023 −$37.37M
Operating Income FY 2024 · Dec 31, 2023 −$40.5M
Stockholders Equity FY 2024 · Dec 31, 2022 $122.34M